Watching EyeCRO! When you look for the best in contract research, you want to see the highest of high tech capabilities. Testing the preclinical efficacy and pharmacokinetics of polymer based drug depots for the retina is not for the faint of heart, and it isn’t your grandma’s ophthalmic test beds. Only the most capable,...
Let’s face it, choosing the wrong contract researcher is short-sighted. Testing the preclinical efficacy and pharmacokinetics of polymer based drug depots for the retina takes serious scientific chops, and a level of expertise that is hard to find. How many researchers and formulation experts can you name that work down to the 100 nm range...
EyeCRO provides consultation to design an appropriate study for your goals and objectives, has a long history of completing projects on time and under budget, and sets itself apart from the large CRO’s through customer service and attention to detail. EyeCRO has fielded the most balanced team of specialists in veterinary medicine, retinopathy, pharmacokinetics,...
EyeCRO is composed of an internationally recognized team of research scientists focused on ophthalmic disease. The company, founded in 2005 with a contract to study the effects of one of the world’s largest pharmaceutical company’s drugs in an animal model, has only grown. EyeCRO started as a way to support the drug pipeline of...
For both in vivo and in vitro retinal disease models and retinopathy preclinical efficacy trials, Eyecro are the new state of the art. Their use of laser technology and rigorous pharmacokinetics for consistent and reliable results is nothing short of amazing. I am very impressed by their ability to study, model, and test treatments...